Home / Products
Watch to learn about the BASHIR™ Endovascular Catheter's exclusive features.
Riyaz Bashir, MD, FACC, RVT, Professor of Medicine for the Lewis Katz School of Medicine at Temple University, (Philadelphia, PA) and Director of Vascular and Endovascular Medicine at Temple University Hospital, created the family of BASHIR™ Endovascular Catheters to dissolve blood clots quickly and effectively, to improve the quality of life for patients suffering from arterial and venous thromboembolic (A+VTE) conditions.
In his words, “VTE has become a significant health concern in the U.S…causing up to 100,000 deaths each year. My inspiration was to develop a device that would provide better treatment outcomes by enhancing both endogenous and exogenous fibrinolysis.”
The Family of Bashir™ Endovascular Catheters
A+VTE is an under-recognized and under-treated condition: it’s the third leading cause of cardiovascular related death.
The family of BASHIR™ Endovascular Catheters are the ﬁrst interventional catheters to rapidly restore blood flow by creating multiple cross sectional channels in the culprit clot, accelerating thrombolysis and optimizing more complete resolution of thrombus burden.
How the family of BASHIR™ Endovascular Catheters work
Immediately forms a large central channel for blood flow through a clot when the mini-infusion catheters are expanded.
Creates a series of cross-sectional channels through the occlusive thrombus, permitting the patient’s own blood flow and its endogenous lytics to begin immediately to dissolve the clot.
Permits infusion of fluids including exogenous lytics to saturate the clot through its 6 mini-infusion catheters with 48 precision-drilled holes intended to synergistically enhance the efficiency of the therapy.
How We're Different
The Proof of Principle Study in a model of thrombosis in the vena cava, using the BASHIR™ Endovascular Catheter with the administration of r-tPA, resulted in 80% lysis of a 30cc clot burden in only 4 hours.
Designed to Enhance Outcomes
The family of BASHIR™ Endovascular Catheters are the first interventional catheters to rapidly create multiple channels so the patient’s own endogenous lytics can flow into the culprit thrombus and immediately begin to dissolve the clot.
1) Mode of Action
Reduces total clot burden
Mechanical expansion of the 6 mini-infusion catheters of the basket creates a large central channel which is designed to allow the patient’s own blood to flow through the clot immediately beginning to dissolve the clot.
This creates a greater surface area within the clot where the endogenous and exogenous lytics accelerate clot lysis, reducing the total clot burden.
BASHIR™ Endovascular Catheter, open basket
The potential to reduce bleeding complications
The family of BASHIR™ Endovascular Cather's patent center lumen uniquely allows the medical team to measure pulmonary artery pressure and mixed venous oxygen saturation during infusion.
This should reduce bleeding complications by allowing for customized patient care.
BASHIR™ Endovascular Catheter - Short Basket
3) Ease of Use and Cost-Effective Care
Minimal change to workflow and simple to use
By employing standard interventional techniques the family of BASHIR™ Endovascular Catheters are easy to use and do not require the purchase of expensive additional capital equipment.
This enables a more cost-effective and efficient approach across the patient care continuum.
BASHIR™ Endovascular Catheter, closed basket
The family of BASHIR™ Endovascular Catheters should play a key role in improving the quality of life for patients suffering from A+VTE conditions.
Need more details? Contact us.
We are here to assist. Contact us by phone, email or via our social media channels.